ArticleAnnals of surgical oncology2025

ASO Author Reflections: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.

Mohammad Saad Farooq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.